Fulgent Genetics, Inc. has grown revenue 1.8% a year over three years and −19% a year over five. Revenue growth, 3-year annual rate: +1.8% (Diagnostics & Research median +8.4%). Revenue growth, 5-year rate: −19%, growth has picked up over the last three years. Years of annual history on file: 12, FY2014 to FY2025, as filed.

FLGTFulgent Genetics, Inc.

Healthcare

$20.87-7.8% 1Y

$20.87

$13.7952 weeks$30.85

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−14.2 points).

1 to watch, 1 neutral, 1 without data

Revenue trend+7% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −19% a year.

Margin direction−14.2 points operating

Trailing-twelve-month operating margin, -38.2% now against -24.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is FLGT growing?

Fulgent Genetics, Inc. has grown revenue 1.8% a year over three years and −19% a year over five.

+1.8%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −19%
Revenue growth, 5-year rate · +1.8% over three · growth has picked up over the last three years
Years of annual history on file: 12
Years of annual history on file · FY2014 to FY2025, as filed

Details›